Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 99,800 shares at $171.63 ($16.4M) on 2024-12-13, disclosed to the SEC on 2024-12-13.
Scheduled sale ($16.4M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.04 | 5,942 | $969K | 5.9% |
| 2 | $163.04 | 5,942 | $969K | 5.9% |
| 3 | $163.07 | 6,302 | $1.0M | 6.2% |
| 4 | $163.07 | 6,302 | $1.0M | 6.2% |
| 5 | $163.91 | 8,381 | $1.4M | 8.4% |
| 6 | $163.91 | 8,381 |
| $1.4M |
| 8.4% |
| 7 | $163.92 | 8,923 | $1.5M | 8.9% |
| 8 | $163.92 | 8,923 | $1.5M | 8.9% |
| 9 | $164.92 | 4,723 | $779K | 4.7% |
| 10 | $164.92 | 4,723 | $779K | 4.7% |
| 11 | $164.93 | 4,909 | $810K | 4.9% |
| 12 | $164.93 | 4,909 | $810K | 4.9% |
| 13 | $165.79 | 2,114 | $350K | 2.1% |
| 14 | $165.79 | 2,114 | $350K | 2.1% |
| 15 | $165.82 | 1,977 | $328K | 2.0% |
| 16 | $165.82 | 1,977 | $328K | 2.0% |
| 17 | $166.93 | 923 | $154K | 0.9% |
| 18 | $166.93 | 923 | $154K | 0.9% |
| 19 | $166.96 | 798 | $133K | 0.8% |
| 20 | $166.96 | 798 | $133K | 0.8% |
| 21 | $168.31 | 200 | $34K | 0.2% |
| 22 | $169.48 | 953 | $162K | 1.0% |
| 23 | $169.48 | 953 | $162K | 1.0% |
| 24 | $169.65 | 911 | $155K | 0.9% |
| 25 | $169.65 | 911 | $155K | 0.9% |
| 26 | $170.43 | 727 | $124K | 0.8% |
| 27 | $170.43 | 727 | $124K | 0.8% |
| 28 | $170.47 | 957 | $163K | 1.0% |
| 29 | $170.47 | 957 | $163K | 1.0% |
| 30 | $171.62 | 620 | $106K | 0.6% |
| 31 | $171.62 | 620 | $106K | 0.6% |
| 32 | $171.63 | 640 | $110K | 0.7% |
| 33 | $171.63 | 640 | $110K | 0.7% |
| Total | $164.79 avg | 99,800 | $16.4M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |